BRAF/MEK inhibitor-induced tumor lysis syndrome in a patient with malignant melanoma

被引：0
|
作者：
Maeda, Shintaro [1 ]
Imazaki, Katsuya [1 ]
Shimizu, Kyoko [1 ]
Oishi, Kyosuke [1 ]
Hamaguchi, Yasuhito [1 ]
Matsushita, Takashi [1 ]
机构：
[1] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Fac Med, Dept Mol Pathol Skin, 13-1 Takaramachi, Kanazawa, Ishikawa 9208641, Japan
来源：
JOURNAL OF DERMATOLOGY | 2025年 / 52卷 / 03期
关键词：
D O I：
10.1111/1346-8138.17507
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：e242 / e243
页数：2
相关论文
共 50 条
  • [31] SKAP2-BRAF fusion and response to an MEK inhibitor in a patient with metastatic melanoma resistant to immunotherapy
    Chew, Sonya Minmin
    Lucas, Mairi
    Brady, Michelle
    Kelly, Catherine Margaret
    BMJ CASE REPORTS, 2021, 14 (06)
  • [32] A case of malignant transformation of a serous borderline ovarian tumor effectively treated with BRAF/MEK inhibitor combination
    Singh, Manrose
    Cornwell, Samantha
    Shaddaie, Ariel
    Wachsmuth, Leah
    Ragupathi, Ashwin
    Salichos, Leonidas
    Nissel-Horowitz, Sandra
    Roy, Rajasree
    Plummer, Maria
    Zhang, Dong
    Mehrotra, Bhoomi
    GYNECOLOGIC ONCOLOGY REPORTS, 2024, 54
  • [33] Rapidly developed BRAF inhibitor-induced verrucous keratosis
    Nakamura, Yoshio
    Mori, Taisuke
    Takae, Yujiro
    Tsutsumida, Arata
    Takahashi, Akira
    Namikawa, Kenjiro
    Hirai, Ikuko
    Yamazaki, Naoya
    JOURNAL OF DERMATOLOGY, 2017, 44 (11): : E274 - E275
  • [34] Response to Ipilimumab/Nivolumab Rechallenge and BRAF Inhibitor/MEK Inhibitor Rechallenge in a Patient with Advanced Metastatic Melanoma Previously Treated with BRAF Targeted Therapy and Immunotherapy
    Myrdal, Caitlyn N.
    Sundararajan, Srinath
    CASE REPORTS IN ONCOLOGICAL MEDICINE, 2020, 2020
  • [35] Is there any interest in a new BRAF-MEK inhibitor combination in melanoma?
    Grob, Jean Jacques
    LANCET ONCOLOGY, 2018, 19 (05): : 580 - 581
  • [36] BRAF-MEK inhibitor combo approved for adjuvant melanoma therapy
    De Lartigue, Jane
    JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY, 2018, 16 (06): : E228 - E230
  • [37] Differential activity of MEK and ERK inhibitors in BRAF inhibitor resistant melanoma
    Carlino, Matteo S.
    Todd, Jason R.
    Gowrishankar, Kavitha
    Mijatov, Branka
    Pupo, Gulietta M.
    Fung, Carina
    Snoyman, Stephanie
    Hersey, Peter
    Long, Georgina V.
    Kefford, Richard F.
    Rizos, Helen
    MOLECULAR ONCOLOGY, 2014, 8 (03) : 544 - 554
  • [38] Combination therapy for melanoma with BRAF/MEK inhibitor and immune checkpoint inhibitor: a mathematical model
    Lai, Xiulan
    Friedman, Avner
    BMC SYSTEMS BIOLOGY, 2017, 11
  • [39] BRAF and MEK inhibitor-associated optic neuropathy in stage IIIC BRAF plus melanoma
    Carrabba, Nicole V.
    Siliezar, Pamela Davila
    Laylani, Noor
    Lee, Andrew G.
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2023, 58 (06): : E251 - E253
  • [40] BRAF Inhibitor Encorafenib plus MEK Inhibitor Binimetinib is effective in leptomeningeal Metastasis of Melanoma
    Steininger, J.
    Kuske, M.
    Beissert, S.
    Meier, F.
    Becker, S.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2020, 18 : 83 - 84
12345